Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Revisit the oncologic emergency, hypercalcemia of malignancy, including risk factors, manifestations, assessment, treatment, and nursing interventions.
Hypercalcemia of malignancy (HCM) is a common paraneoplastic syndrome associated with poor prognosis that affects approximately 20%–30% of patients with cancer. It’s most often seen in patients with breast, lung, renal, or ovarian cancers; squamous cell carcinoma of the head and neck; multiple myeloma; and certain lymphomas.